Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels

被引:0
|
作者
Aurora Veteleanu
Joshua Stevenson-Hoare
Samuel Keat
Nikoleta Daskoulidou
Henrik Zetterberg
Amanda Heslegrave
Valentina Escott-Price
Julie Williams
Rebecca Sims
Wioleta M. Zelek
Sarah M. Carpanini
Bryan Paul Morgan
机构
[1] Cardiff University,UK Dementia Research Institute Cardiff, School of Medicine
[2] Cardiff University,Neurosciences and Mental Health Institute
[3] UK Dementia Research Institute at University College London,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Psychology
[4] The Sahlgrenska Academy at the University of Gothenburg,Clinical Neurochemistry Laboratory
[5] Sahlgrenska University Hospital,Department of Neurodegenerative Disease
[6] UCL Institute of Neurology,Division of Psychological Medicine and Clinical Neurosciences
[7] Queen Square,undefined
[8] Hong Kong Center for Neurodegenerative Diseases,undefined
[9] Cardiff University,undefined
关键词
Alzheimer’s disease; Complement system; Biomarkers; Clusterin; Complement receptor 1; C1s; C1q; Factor H; GWAS;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Avoiding bad complement in Alzheimer's disease
    Flight, Monica Hoyos
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (09) : 697 - 697
  • [22] Avoiding bad complement in Alzheimer's disease
    Monica Hoyos Flight
    Nature Reviews Neuroscience, 2009, 10 : 623 - 623
  • [23] Complement activation by the Alzheimer's disease β-peptide
    Bradt, BM
    Cooper, NR
    MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 337 - 337
  • [24] The role of complement in Alzheimer's disease pathology
    Emmerling, MR
    Watson, MD
    Raby, CA
    Spiegel, K
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01): : 158 - 171
  • [25] Serum complement factor H levels in late onset Alzheimer's disease
    Yilmazer, S.
    Gezen-Ak, D.
    Dursun, E.
    Hanagasi, H.
    Bilgic, B.
    Lohman, E.
    Araz, O. S.
    Atasoy, I.
    Alaylioglu, M.
    Onal, B.
    Gurvit, H.
    FEBS JOURNAL, 2013, 280 : 430 - 430
  • [26] Cromolyn Reduces Levels of the Alzheimer’s Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis
    Can Zhang
    Ana Griciuc
    Eloise Hudry
    Yu Wan
    Luisa Quinti
    Joseph Ward
    Angela M. Forte
    Xunuo Shen
    ChongZhao Ran
    David R. Elmaleh
    Rudolph E. Tanzi
    Scientific Reports, 8
  • [27] Complement Gene Single Nucleotide Polymorphisms and Biomarker Endophenotypes of Alzheimer's Disease
    Daborg, Jonny
    Holmgren, Sandra
    Abramsson, Alexandra
    Andreasson, Ulf
    Zetterberg, Madeleine
    Nilsson, Staffan
    Minthon, Lennart
    Skoog, Ingmar
    Blennow, Kaj
    Pekna, Marcela
    Hanse, Eric
    Zetterberg, Henrik
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (01) : 51 - 57
  • [28] Multimerization of TREM2 is impaired by Alzheimer's disease-associated variants
    Dean, Hunter B.
    Greer, Rory A.
    Yang, Shan-Zhong
    Elston, Daniel S.
    Brett, Thomas J.
    Roberson, Erik D.
    Song, Yuhua
    ALZHEIMERS & DEMENTIA, 2024, 20 (09) : 6332 - 6350
  • [29] Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants
    Amlie-Wolf, Alexandre
    Tang, Mitchell
    Way, Jessica
    Dombroski, Beth
    Jiang, Ming
    Vrettos, Nicholas
    Chou, Yi-Fan
    Zhao, Yi
    Kuzma, Amanda
    Mlynarski, Elisabeth E.
    Leung, Yuk Yee
    Brown, Christopher D.
    Wang, Li-San
    Schellenberg, Gerard D.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 72 (01) : 301 - 318
  • [30] Alzheimer's disease risk factor complement receptor 1 is associated with depression
    Hamilton, Gillian
    Evans, Kathryn L.
    MacIntyre, Donald J.
    Deary, Ian J.
    Dominiczak, Anna
    Smith, Blair H.
    Morris, Andrew D.
    Porteous, David J.
    Thomson, Pippa A.
    NEUROSCIENCE LETTERS, 2012, 510 (01) : 6 - 9